EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A cost analysis of a simplified model for HCV screening and treatment at a tertiary hospital in Zimbabwe

Blessing Dzingirai iD, Leolin Katsidzira, Vongai Mwanesani, Maarten Jacobus Postma, Marinus van Hulst, Nyashadzaishe Mafirakureva

Expert Review of Pharmacoeconomics & Outcomes Research · 2024

DOI: 10.1080/14737167.2024.2348055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Expert Review of Pharmacoeconomics & Outcomes Research, 2024. Verfasst von Blessing Dzingirai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Global Health, Department of Health Sciences, Üniversity of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Hauptthemen laut MEDLINE: Tertiary Care Centers, Antiviral Agents, Mass Screening, Hepatitis C, Chronic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The treatment of chronic hepatitis C virus (HCV) infection using directly acting antivirals was recently adopted in the treatment guidelines of Zimbabwe. The objectives of this study were to design a simplified model of HCV care and estimate the cost of screening and treatment of hepatitis C infection at a tertiary hospital in Zimbabwe. METHODS: We developed a model of care for HCV using WHO 2018 guidelines for the treatment of HCV infection and expert opinion. We then performed a micro-costing to estimate the costs of implementing the model of care from the healthcare sector perspective. Deterministic and probabilistic sensitivity analyses were performed to explore the impact of uncertainty in input parameters on the estimated total cost of care. RESULTS: The total cost of screening and treatment was estimated to be US$2448 (SD=$290) per patient over a 12-week treatment duration using sofosbuvir/velpatasvir. The cost of directly acting antivirals contributed 57.5% to the total cost of care. The second largest cost driver was the cost of diagnosis, US$819, contributing 34.6% to the total cost of care. CONCLUSION: Screening and treatment of HCV-infected individuals using directly acting antivirals at a tertiary hospital in Zimbabwe may require substantial financial resources.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tertiary Care CentersAntiviral AgentsMass ScreeningHepatitis C, ChronicHealth Care CostsHumansZimbabwePractice Guidelines as TopicCosts and Cost AnalysisModels, Economic

Stichwörter der Autor:innen

Hepatitis CZimbabwecost analysismicro-costingsimplified model of caretreatment guidelines

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Unit of Global Health, Department of Health Sciences, Üniversity of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Department of Pharmacy and Pharmaceutical Sciences, University of Zimbabwe, Harare, Zimbabwe.
  • Department of Medicine, College of Health Sciences University of Zimbabwe, Harare, Zimbabwe.
  • Department of Clinical Pharmacy and Toxicology, Martini Hospital, Groningen, The Netherlands.
  • Health Economics and Decision Science, School of Health and Related Research, University of Sheffield, Sheffield, UK.

ORCID-Profile: Blessing Dzingirai

Zitieren

APA

Dzingirai, B., Katsidzira, L., Mwanesani, V., Postma, M. J., van Hulst, M., & Mafirakureva, N. (2024). A cost analysis of a simplified model for HCV screening and treatment at a tertiary hospital in Zimbabwe. Expert Review of Pharmacoeconomics & Outcomes Research. https://doi.org/10.1080/14737167.2024.2348055

Vancouver

Dzingirai B, Katsidzira L, Mwanesani V, Postma MJ, van Hulst M, Mafirakureva N. A cost analysis of a simplified model for HCV screening and treatment at a tertiary hospital in Zimbabwe. Expert Review of Pharmacoeconomics & Outcomes Research. 2024. doi:10.1080/14737167.2024.2348055

BibTeX
@article{Dzingirai2024,
  author = {Dzingirai, Blessing and Katsidzira, Leolin and Mwanesani, Vongai and Postma, Maarten Jacobus and van Hulst, Marinus and Mafirakureva, Nyashadzaishe},
  title = {A cost analysis of a simplified model for HCV screening and treatment at a tertiary hospital in Zimbabwe},
  journal = {Expert Review of Pharmacoeconomics & Outcomes Research},
  year = {2024},
  doi = {10.1080/14737167.2024.2348055}
}
Kostenlos starten →